Source: Annual Congress 2006 - Immunological diagnosis of tuberculosis infection and disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. M. L. van Leeuwen, A. W. J. Bossink, S. F. T. Thijsen (Utrecht, Netherlands). Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease. Eur Respir J 2006; 28: Suppl. 50, 874

Member's Comments

No comment yet.

Related content which might interest you: Comparison of the tuberculin skin test and two commercial blood tests for diagnosing active mycobacterium tuberculosis infection and nontuberculous mycobacterium infection Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006 Evaluation of a IFN-γ test using Mycobacterium tuberculosis-specific antigens for diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 142s Year: 2006 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis Source: Eur Respir J 2010; 35: 338-342 Year: 2010 Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay Source: Eur Respir J 2007; 29: 605-607 Year: 2007 Latent tuberculosis Source: Respipedia Article Year: 2018 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Non-tuberculous mycobacteria effect in the diagnosis of latent tuberculosis infection in children Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006 Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009